Key Insights on DuPont de Nemours – A Comprehensive Overview

Large-cap Industrials company DuPont de Nemours has moved 2.8% so far today on a volume of 6,006,315, compared to its average of 2,497,585. In contrast, the S&P 500 index moved 1.0%.

DuPont de Nemours trades -6.47% away from its average analyst target price of $86.73 per share. The 14 analysts following the stock have set target prices ranging from $74.0 to $101.0, and on average have given DuPont de Nemours a rating of buy.

If you are considering an investment in DD, you'll want to know the following:

  • DuPont de Nemours's current price is 140.4% above its Graham number of $33.74, which implies that at its current valuation it does not offer a margin of safety

  • DuPont de Nemours has moved 18.0% over the last year, and the S&P 500 logged a change of 26.1%

  • Based on its trailing earnings per share of 0.92, DuPont de Nemours has a trailing 12 month Price to Earnings (P/E) ratio of 88.2 while the S&P 500 average is 15.97

  • DD has a forward P/E ratio of 19.1 based on its forward 12 month price to earnings (EPS) of $4.25 per share

  • The company has a price to earnings growth (PEG) ratio of 2.05 — a number near or below 1 signifying that DuPont de Nemours is fairly valued compared to its estimated growth potential

  • Its Price to Book (P/B) ratio is 1.44 compared to its sector average of 4.06

  • DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa.

  • Based in Wilmington, the company has 24,000 full time employees and a market cap of $33.92 Billion. DuPont de Nemours currently returns an annual dividend yield of 1.8%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.